Organization Overview
Alternative names
acetylsalicylic acid (aspirin) (19 trials)
adalimumab (humira) (3 trials)
albumin (Human) (Plasbumin) (1 trial)
alendronic acid (fosamax) (1 trial)
allogeneic cord blood (1 trial)
alteplase (Activase) (1 trial)
amlodipine (norvasc) (2 trials)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (6 trials)
atorvastatin (lipitor) (7 trials)
attenuated measles vaccine - Edmonston strain (rubeovax) (1 trial)
autologous mesenchymal stem cells (6 trials)
belimumab (benlysta) (2 trials)
betamethasone (celestone) (1 trial)
bictegravir (Biktarvy) (1 trial)
bifidobacterium animalis (3 trials)
bivalirudin (angiomax) (2 trials)
bortezomib (velcade) (13 trials)
bupropion (wellbutrin) (1 trial)
calcitriol (rocaltrol) (1 trial)
canagliflozin (invokana) (1 trial)
capecitabine (xeloda) (53 trials)
caspofungin (cancidas) (1 trial)
cisplatin (platinol) (83 trials)
clopidogrel (plavix) (13 trials)
conjugated equine estrogens (Premarin) (1 trial)
crizotinib (xalkori) (2 trials)
cyclophosphamide (cytoxan) (44 trials)
cyclosporine (sandimmune) (10 trials)
cytarabine (cytosar-u) (19 trials)
desogestrel (Mercilon) (1 trial)
dexmedetomidine (precedex) (4 trials)
doxorubicin (Doxil) (19 trials)
dydrogesterone (gynorest) (2 trials)
efavirenz (sustiva) (5 trials)
eltrombopag (promacta) (4 trials)
empagliflozin (jardiance) (1 trial)
emtricitabine (emtriva) (1 trial)
enoxaparin (lovenox) (1 trial)
enterococcus faecium (1 trial)
ethinyl estradiol (Estinyl) (2 trials)
etoposide (vepesid) (24 trials)
everolimus (zortress) (2 trials)
exemestane (aromasin) (5 trials)
Filgrastim (neupogen) (19 trials)
flumazenil (mazicon ) (1 trial)
glimepiride (amaryl) (1 trial)
hepatitis a (live) vaccine (2 trials)
hepatitis a vaccine, inactivated (vaqta) (2 trials)
hepatitis b vaccine (recombinant) (Recombivax) (1 trial)
human factor ix complex (prothrombin complex concentrate) (Bebulin) (1 trial)
human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil) (1 trial)
hydrocortisone (solu-cortef) (2 trials)
idarubicin (idamycin) (5 trials)
inactivated sabin strain polio virus (1 trial)
insulin human (humulin) (1 trial)
interferon alpha-2b (Intron-A) (6 trials)
Lactobacillus acidophilus (4 trials)
lamivudine (epivir) (3 trials)
lenalidomide (revlimid) (9 trials)
levothyroxine (Synthroid) (3 trials)
live attenuated chimeric japanese encephalitis vaccine (1 trial)
metformin (glucophage) (5 trials)
methylprednisolone (medrol) (3 trials)
metoprolol (lopressor) (2 trials)
mirabegron (myrbetriq) (1 trial)
mirtazapine (remeron) (1 trial)
Monovalent group A meningococcal vaccine (Menomune-A) (2 trials)
montelukast (singulair) (1 trial)
oxycodone (oxycontin) (1 trial)
pegaspargase (oncaspar) (6 trials)
pemetrexed (alimta) (15 trials)
pioglitazone (actos) (1 trial)
pitavastatin (livalo) (2 trials)
polio, inactivated poliovirus vaccine (Salk Vaccine) (5 trials)
pomalidomide (pomalyst) (3 trials)
pramipexole (mirapex) (1 trial)
prednisolone (hydeltra) (4 trials)
prednisone (meticorten) (29 trials)
propofol (diprivan) (6 trials)
remifentanil (ultiva) (1 trial)
remimazolam (Byfavo) (5 trials)
rituximab (rituxan) (32 trials)
rivaroxaban (xarelto) (2 trials)
rocuronium (zemuron) (1 trial)
sargramostim (leukine) (6 trials)
simvastatin (zocor) (3 trials)
sirolimus (rapamune) (10 trials)
sitagliptin (januvia) (2 trials)
sodium glycididazole (1 trial)
sugammadex (bridion) (2 trials)
sulfisoxazole (gantrisin) (1 trial)
tacrolimus (prograf) (3 trials)
telmisartan (micardis) (1 trial)
tenecteplase (tnkase) (1 trial)
tenofovir alafenamide (genvoya) (1 trial)
thalidomide (Thalomid) (8 trials)
thymalfasin (zadaxin) (3 trials)
ticagrelor (brilinta) (5 trials)
tocilizumab (actemra) (5 trials)
tranexamic acid (cyklokapron) (10 trials)
trastuzumab (herceptin) (12 trials)
unfractionated heparin (1 trial)
ursodeoxycholic acid (3 trials)
vincristine (oncovin) (14 trials)
vinorelbine (navelbine) (13 trials)
131i-lipiodol (Lipiodol) (1 trial)
acalabrutinib (calquence) (2 trials)
acetaminophen (tylenol) (1 trial)
adapalene (differin) (2 trials)
aflibercept (zaltrap) (2 trials)
anastrozole (arimidex) (3 trials)
antigen pulsed dendritic cells (1 trial)
antihemophilic factor viii (Recombinant) (Adynovate) (2 trials)
antihemophilic factor viii (Recombinant), Fc-fusion protein (Eloctate) (4 trials)
autologous bone marrow derived mesenchymal cells (1 trial)
azacitidine (vidaza) (6 trials)
Bacterial Lysates (pulmonarom) (1 trial)
bendamustine (treanda) (3 trials)
bevacizumab (avastin) (16 trials)
bifidobacterium lactis (1 trial)
Bivalent group A and C meningococcal vaccine (Menomune-A/C) (1 trial)
bivalent oral polio vaccine (bopv), type 1 and type 3 (BOPV) (2 trials)
carboplatin (paraplatin) (41 trials)
cetuximab (erbitux) (7 trials)
chlorambucil (Leukeran) (2 trials)
cilostazol (pletal) (2 trials)
dacarbazine (dtic-dome) (2 trials)
daunorubicin (cerubidine) (6 trials)
decitabine (dacogen) (8 trials)
dendrobium huoshanense (1 trial)
docetaxel (taxotere) (29 trials)
durvalumab (imfinzi) (7 trials)
endostatin (endostar) (15 trials)
epirubicin (ellence) (17 trials)
erlotinib (tarceva) (3 trials)
etanercept (enbrel) (2 trials)
fludarabine (fludara) (11 trials)
fluorouracil (efudex) (29 trials)
flurbiprofen (ansaid) (1 trial)
fulvestrant (faslodex) (7 trials)
gemcitabine (gemzar) (21 trials)
hetrombopag olamine (4 trials)
icotinib (Conmana) (16 trials)
immune globulin (human) (Gamastan) (1 trial)
inactivated influenza vaccine (3 trials)
inactivated japanese encephalitis vaccine (Ixiaro) (1 trial)
inactivated SARS-Cov-2 vaccine (7 trials)
indomethacin (indocin) (1 trial)
interferon alpha-2a (roferon-a) (1 trial)
lactobacillus plantarum (1 trial)
lapatinib (tykerb) (42 trials)
lenvatinib (lenvima) (12 trials)
live attenuated mumps vaccine (Jeryl Lynn strain) (3 trials)
live oral poliovirus type 1, 2 and 3 (Trivalent oral polio vaccine - Sabin) (1 trial)
lumefantrine (Coartem) (1 trial)
mercaptopurine (purinethol) (4 trials)
oprelvekin (Neumega) (2 trials)
osimertinib (tagrisso) (3 trials)
oxaliplatin (eloxatin) (51 trials)
procaine benzylpenicillin (novocaine) (1 trial)
ranibizumab (lucentis) (3 trials)
remdesivir (Veklury) (1 trial)
somatropin (protropin) (1 trial)
sorafenib (nexavar) (6 trials)
stanozolol (winstrol) (1 trial)
tamoxifen (nolvadex) (2 trials)
temozolomide (temodar) (14 trials)
thyrotropin (Thyropar) (2 trials)
toremifene (fareston) (1 trial)
abiraterone (zytiga) (1 trial)
acetylcysteine (mucomyst) (1 trial)
afatinib (gilotrif) (2 trials)
aldesleukin (Proleukin) (2 trials)
alectinib (alecensa) (1 trial)
allogeneic adipose derived mesenchymal stem cell (1 trial)
allogeneic central memory t cells (1 trial)
allogeneic hematopoietic stem cells (Hemacord) (1 trial)
arsenic trioxide (trisenox) (2 trials)
asparaginase (elspar) (1 trial)
astragalus membranaceus (1 trial)
atezolizumab (Tecentriq) (1 trial)
autologous adipose-derived mesenchymal stem cells (1 trial)
autologous adipose tissue (1 trial)
autologous gp96 vaccination (1 trial)
autologous hematopoietic stem cells (1 trial)
autologous lymphocytes (1 trial)
autologous mesenchymal stem cell-derived neural progenitors (2 trials)
autologous mononuclear stem cell (1 trial)
autologous T cell memory cells (2 trials)
avapritinib (Ayvakit) (1 trial)
bacille calmette-guerin (1 trial)
baricitinib (olumiant) (2 trials)
bicalutamide (casodex) (1 trial)
bone marrow derived mesenchymal stem cells (1 trial)
celecoxib (celebrex) (1 trial)
chlorpheniramine (ChlorTrimeton) (1 trial)
ciltacabtagene autoleucel (Carvykti) (4 trials)
dacomitinib (vizimpro) (1 trial)
daratumumab (darzalex) (2 trials)
dendritic cell activated cytokine-induced killer cell (1 trial)
desflurane (suprane) (1 trial)
encorafenib (braftovi) (1 trial)
esophageal cancer peptide specific ctl (1 trial)
etirinotecan pegol (Onzeald) (2 trials)
ferric carboxymaltose (Injectafer) (1 trial)
fruquintinib (Inrebic) (4 trials)
furmonertinib (Ives) (1 trial)
human fecal microbiota (Reybota) (2 trials)
hydroxychloroquine (plaquenil) (2 trials)
ibrutinib (imbruvica) (3 trials)
inotuzumab ozogamicin (besponsa) (2 trials)
itraconazole (sporanox) (1 trial)
levamisole (ergamisol) (4 trials)
levoleucovorin (fusilev) (1 trial)
loratadine (claritin) (1 trial)
luspatercept (Reblozyl) (1 trial)
measles and mumps vaccine (M-M-Vax) (1 trial)
medroxyprogesterone (provera) (1 trial)
melphalan (alkeran) (3 trials)
mitomycin (mutamycin) (1 trial)
mitoxantrone (novantrone) (6 trials)
monosialoganglioside (1 trial)
neratinib maleate (nerlynx) (1 trial)
olanzapine (zyprexa) (1 trial)
parathyroid hormone (Natpara) (1 trial)
pd-1 knockout t cells (1 trial)
pemigatinib (Pemazyre) (1 trial)
periplaneta americana (1 trial)
prochlorperazine (compazine) (1 trial)
recombinant human adenovirus type 5 (1 trial)
recombinant humanized anti-interleukin-6 receptor monoclonal antibody (1 trial)
Recombinant Human Type-5 Adenovirus (Gendicine) (1 trial)
regorafenib (stivarga) (2 trials)
romiplostim (nplate) (1 trial)
sacituzumab govitecan (Trodelvy) (1 trial)
sodium iodide i-131 (iodotope) (1 trial)
topotecan (hycamtin) (1 trial)
tripterygium wilfordii (1 trial)
triptorelin (Trelstar) (1 trial)
umbilical cord mesenchymal stem cells (15 trials)
valaciclovir (Valtrex) (1 trial)
vemurafenib (zelboraf) (1 trial)
vindesine (Eldisine) (1 trial)
wharton's jelly mesenchymal stem cells (2 trials)
68ga-1,4,7-triazacyclononane-n,n',n''-triacetic acid (1 trial)
68ga-bbn-irdye800cw (2 trials)
[68ga]ga-hbed-cc-exendin-4 (1 trial)
allogeneic gamma-delta t cells (2 trials)
autologous cd19/cd22 chimeric antigen receptor t-cells (2 trials)
car-cldn18.2 t-cells (1 trial)
cd19/cd20 bispecific car-t cells (1 trial)
choline c11 (choline c-11) (2 trials)
Embryonic Stem Cells (1 trial)
enfuvirtide (fuzeon) (2 trials)
fludeoxyglucose f-18 (5 trials)
gallium-68-dotatate (netspot) (2 trials)
human embryonic stem cell derived retinal pigmented epithelial cells (1 trial)
human single chain il-12 mrna-multiple dose (1 trial)
inactivated rotavirus vaccine (1 trial)
indocyanine green (ic-green) (3 trials)
live attenuated mumps (f-genotype) vaccine (1 trial)
lutetium (177Lu) vipivotide tetraxetan (Pluvicto) (5 trials)
lutetium dotatate lu-177 (Lutathera) (1 trial)
masct:multiple antigens specific cellular therapy (1 trial)
mianhuahua flavonoids (1 trial)
amino acids (Freamine) (1 trial)
anti-gpc3-irdye800cw (1 trial)
autologous umbilical cord blood (1 trial)
azathioprine (imuran) (1 trial)
bromocriptine (parlodel) (2 trials)
cabergoline (dostinex) (3 trials)
cefoperazone (cefobid) (1 trial)
doxycycline (vibramycin) (1 trial)
entecavir (baraclude) (1 trial)
escitalopram (lexapro) (1 trial)
felodipine (plendil) (1 trial)
fish oil (Omegavan) (2 trials)
formyltetrahydrofolate (1 trial)
frovatriptan (frova) (1 trial)
glipizide (glucotrol) (1 trial)
glycopyrronium (robinul) (1 trial)
hiv-1 specific car-t cells (1 trial)
hydrochlorothiazide (esidrix) (1 trial)
leflunomide (arava) (3 trials)
loperamide (imodium) (1 trial)
methylene blue (proveblue) (2 trials)
naratriptan (amerge) (1 trial)
neostigmine (bloxiverz) (1 trial)
nesiritide (natrecor) (1 trial)
octreotide (sandostatin) (1 trial)
onabotulinumtoxinA (Botox) (1 trial)
oxytocin (syntocinon) (1 trial)
rice allergenic extract (1 trial)
rizatriptan (maxalt) (1 trial)
ropivacaine (naropin) (7 trials)
sars-cov-2 mrna vaccine immunization (1 trial)
soybean oil (Intralipid) (1 trial)
sumatriptan (zecuity) (1 trial)
tremelimumab (Imjudo) (1 trial)
whole wheat allergenic extract (1 trial)
zidovudine (retrovir) (1 trial)
Acne Vulgaris (Phase 3)
Acquired Hyperostosis Syndrome (Phase 1)
Acquired Immunodeficiency Syndrome (Phase 1)
Acute Coronary Syndrome (Phase 4)
Acute Disease (Phase 2)
Acute Lung Injury (Phase 2)
Adenocarcinoma (Phase 4)
Adenocarcinoma, Mucinous (Phase 2)
Adenocarcinoma of Lung (Phase 3)
Adenoma (Phase 3)
Adenoma, Islet Cell (Phase 2)
Adenoviridae Infections (Phase 1)
Airway Remodeling (Phase 4)
Amyloidosis (Phase 2)
Anemia (Phase 4)
Anemia, Aplastic (Phase 4)
Anemia, Hemolytic (Phase 4)
Anemia, Hemolytic, Autoimmune (Phase 4)
Anemia, Iron-Deficiency (Phase 2)
Anus Neoplasms (Phase 2)
Aortic Arch Syndromes (Phase 3)
Aortic Valve Stenosis (Phase 4)
Arteritis (Phase 3)
Arthritis (Phase 3)
Arthritis, Juvenile (Phase 1)
Arthritis, Rheumatoid (Phase 3)
Asthma (Phase 4)
Astrocytoma (Phase 3)
Atherosclerosis (Phase 3)
Atrial Fibrillation (Phase 4)
Autoimmune Diseases (Phase 2)
Behcet Syndrome (Phase 3)
Biliary Tract Neoplasms (Phase 2)
Bradycardia (Phase 4)
Brain Injuries (Phase 1)
Brain Neoplasms (Phase 3)
Brain Stem Neoplasms (Phase 2)
Breast Diseases (Phase 3)
Breast Neoplasms (Phase 4)
Bronchiectasis (Phase 3)
